To prevent unauthorised sale, unsupervised use, and other malpractices, the Drug Controller of India has intensified its regulatory surveillance, warning that the drugs can lead to serious side effects if not taken under strict medical supervision
Prescription treatment requires evaluation by a licensed clinician
avoid freeze-thaw cycling of reconstituted solution and protect from light
Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval framework." Hims & Hers started selling a compounded version of injectable semaglutide in 2024, while the drug was still deemed to be in short supply
Hiramatsu T, Ozeki A, Ishikawa H, Furuta S